Jason B. Shandell, President and General Counsel at Amphastar Pharmaceuticals, Inc. (AMPH), sold 104,592 shares at $20.68 ($2.2M) on 2018-11-08, disclosed to the SEC on 2018-11-09.
Open-market sale of $2.2M AMPH by President and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.68 | 36,201 | $749K | 34.5% |
| 2 | $20.68 | 36,201 | $749K | 34.5% |
| 3 | $20.99 | 16,095 | $338K | 15.5% |
| 4 | $20.99 | 16,095 | $338K | 15.5% |
| Total | $20.78 avg | 104,592 | $2.2M | 100% |
| Filing → |
| AMPH | SELL | 2019-12-20 | $314K | — | Filing → |
| AMPH | SELL | 2019-09-20 | $313K | — | Filing → |
| AMPH | SELL | 2019-07-12 | $269K | — | Filing → |